A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation

被引:30
作者
Makar, KW
Ulgiati, D
Hagman, J
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[3] Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA
关键词
B lymphocytes; CBF1; cellular differentiation; complement; gene regulation; transcription factors;
D O I
10.1093/intimm/13.5.657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expression of human complement receptor type 2 (CR2/CD21) is primarily restricted to mature a cells and follicular dendritic cells. We previously described an intronic transcriptional silencer that controls the appropriate B cell-specific and developmentally restricted expression of human CR2/CD21 in both stably transfected cell lines and transgenic mice. Here we report the identification of a nucleotide sequence within the 2.5 kb CR2 silencer (CRS) that is crucial to its silencer function. This site comprises a binding site for the transcriptional repressor CBF1 (RBP-J or RBP-J kappa) as well as Spl and other as yet uncharacterized proteins. A 2-bp mutation which eliminates the binding of CBF1 and other protein(s) in vitro results in loss of silencer activity in vivo. These results demonstrate the importance of this site in regulating CR2 expression and suggest that CBF1, a component of the developmentally important Notch signaling pathway, may play a role in the control of human CR2 gene expression.
引用
收藏
页码:657 / 664
页数:8
相关论文
共 40 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]   NOTCH SIGNALING [J].
ARTAVANISTSAKONAS, S ;
MATSUNO, K ;
FORTINI, ME .
SCIENCE, 1995, 268 (5208) :225-232
[3]   Rel/NF-κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors [J].
Bash, J ;
Zong, WX ;
Banga, S ;
Rivera, A ;
Ballard, DW ;
Ron, Y ;
Gélinas, C .
EMBO JOURNAL, 1999, 18 (10) :2803-2811
[4]   STABLE TRANSFECTION OF EPSTEIN-BARR VIRUS (EBV) NUCLEAR ANTIGEN-2 IN LYMPHOMA-CELLS CONTAINING THE EBV-P3HR1 GENOME INDUCES EXPRESSION OF B-CELL ACTIVATION MOLECULES CD21 AND CD23 [J].
CORDIER, M ;
CALENDER, A ;
BILLAUD, M ;
ZIMBER, U ;
ROUSSELET, G ;
PAVLISH, O ;
BANCHEREAU, J ;
TURSZ, T ;
BORNKAMM, G ;
LENOIR, GM .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1002-1013
[5]   EPSTEIN-BARR-VIRUS (EBV) NUCLEAR-ANTIGEN-2-INDUCED UP-REGULATION OF CD21 AND CD23 MOLECULES IS DEPENDENT ON A PERMISSIVE CELLULAR CONTEXT [J].
CORDIERBUSSAT, M ;
BILLAUD, M ;
CALENDER, A ;
LENOIR, GM .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (01) :153-160
[6]   Dependence of germinal center B cells on expression of CD21/CD35 for survival [J].
Fischer, MB ;
Goerg, S ;
Shen, LM ;
Prodeus, AP ;
Goodnow, CC ;
Kelsoe, G ;
Carroll, MC .
SCIENCE, 1998, 280 (5363) :582-585
[7]   Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter [J].
Fitzsimmons, D ;
Hodsdon, W ;
Wheat, W ;
Maira, SM ;
Wasylyk, B ;
Hagman, J .
GENES & DEVELOPMENT, 1996, 10 (17) :2198-2211
[8]   AN INHIBITORY CARBOXYL-TERMINAL DOMAIN IN ETS-1 AND ETS-2 MEDIATES DIFFERENTIAL BINDING OF ETS FAMILY FACTORS TO PROMOTER SEQUENCES OF THE MB-1 GENE [J].
HAGMAN, J ;
GROSSCHEDL, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :8889-8893
[9]   ELIMINATION OF SELF-REACTIVE LYMPHOCYTES-B PROCEEDS IN 2 STAGES - ARRESTED DEVELOPMENT AND CELL-DEATH [J].
HARTLEY, SB ;
COOKE, MP ;
FULCHER, DA ;
HARRIS, AW ;
CORY, S ;
BASTEN, A ;
GOODNOW, CC .
CELL, 1993, 72 (03) :325-335
[10]   Transcriptional regulation during B cell development [J].
Henderson, A ;
Calame, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :163-200